Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 12, 2011, Pages 1749-1756

  Miyazaki, Masayuki ^a   Kato, Masaki ^a   Tanaka, Masatake ^a   Tanaka, Kosuke ^a   Takao, Shinichiro ^a   Kohjima, Motoyuki ^b   Ito, Tetsuhide ^a   Enjoji, Munechika ^c   Nakamuta, Makoto ^b   Kotoh, Kazuhiro ^a   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Acute liver failure; Acute liver injury; Hepatic hemodynamics; Hepatic microcirculation; Intrahepatic shunt; Ultrasonography

Indexed keywords

CORTICOSTEROID; ENTECAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PERFLUBUTANE;

ACUTE LIVER INJURY; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEMODYNAMICS; HEPATIC VEIN; HEPATITIS B; HUMAN; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER INJURY; MALE; MICROCIRCULATION; PORTAL VEIN; PRIORITY JOURNAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

EID: 81855192761     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06790.x     Document Type: Article

References (23)

1. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin. Liver Dis. 1986; 6: 97-106.
2. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005; 11: 594-605.
3. Bernuau J, Goudeau A, Poynard T etal. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-51.
4. O'Grady JG, Alexander GJ, Hayllar KM etal. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
5. Zaman MB, Hoti E, Qasim A etal. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant. Proc. 2006; 38: 2097-8.
6. Arai M, Mochida S, Ohno A etal. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993; 104: 1466-71.
7. Mochida S, Arai M, Ohno A etal. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999; 29: 1532-40.
8. Kotoh K, Enjoji M, Kato M etal. A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: a retrospective study. Comp. Hepatol. 2008; 7: 6-13.
9. Blomley MJ, Cooke JC, Unger EC etal. Microbubble contrast agents: a new era in ultrasound. BMJ 2001; 322: 1222-5.
10. Albrecht T, Blomley MJ, Cosgrove DO etal. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999; 353: 1579-83.
11. Grier S, Lim AK, Patel N etal. Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J. Gastroenterol. 2006; 12: 3461-5.
12. Zheng RQ, Zhang B, Kudo M etal. Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography. World J. Gastroenterol. 2005; 11: 6348-53.
13. Ridolfi F, Abbattista T, Marini F etal. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig. Liver Dis. 2007; 39: 929-35.
14. Fujita Y, Watanabe M, Sasao K etal. Investigation of liver parenchymal flow using contrast-enhanced ultrasound in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 2004; 28: 169S-73S.
15. Lim AK, Patel N, Eckersley RJ etal. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006; 240: 130-5.
16. Molino G, Avagnina P, Ballare M etal. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig. Dis. Sci. 1991; 36: 1189-96.
17. Zoli M, Magalotti D, Bianchi G etal. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J. Hepatol. 1995; 23: 129-34.
18. Pan Z, Wu XJ, Li JS etal. Functional hepatic flow in patients with liver cirrhosis. World J. Gastroenterol. 2004; 10: 915-18.
19. Valla D, Flejou JF, Lebrec D etal. Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology 1989; 10: 482-7.
20. Luyendyk JP, Shaw PJ, Green CD etal. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine. J. Pharmacol. Exp. Ther. 2005; 314: 1023-31.
21. Kashiwagi T, Fukui H, Kozuka T etal. Estimation of portosystemic shunt index in superior mesenteric vein by duodenal administration of 123I-IMP. Nippon Shokakibyo Gakkai Zasshi 1990; 87: 1578.
22. Javle P, Yates J, Kynaston HG etal. Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure. Gut 1998; 43: 272-9.
23. Li XBI, Alexander B. The relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver. Gut 1998; 42: 276-82.